REGENXBIO Inc. Company Information

REGENXBIO Inc.'s employee growth, exchange listings and data sources

Key Information

Name: REGENXBIO Inc.
Ticker: RGNX
Exchange: NasdaqGS
Founded: 2008
Industry: Biotechnology
Sector: Pharmaceuticals & Biotech
Market Cap: US$475.137m
Shares Outstanding: 49.55m
Website: https://www.regenxbio.com

Number of Employees

Location

REGENXBIO Inc.
9804 Medical Center Drive
Rockville
Maryland
20850
United States

Listings

Ticker	Exchange	Primary Security	Security Type	Country	Currency	Listed on
RGNX	NasdaqGS (Nasdaq Global Select)	Yes	Common Shares	US	USD	Sep 2015
RB0	DB (Deutsche Boerse AG)	Yes	Common Shares	DE	EUR	Sep 2015

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
Data	Last Updated (UTC time)
Company Analysis	2024/11/25 09:15
End of Day Share Price	2024/11/25 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.